UnitedHealth Group Incorporated (NYSE:UNH)‘s stock had its “buy” rating reaffirmed by analysts at Jefferies Group LLC in a note issued to investors on Friday. They currently have a $215.00 target price on the healthcare conglomerate’s stock. Jefferies Group LLC’s price target would suggest a potential upside of 11.57% from the stock’s current price.

UNH has been the subject of a number of other research reports. Deutsche Bank AG restated a “buy” rating and set a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. UBS AG restated a “buy” rating and issued a $194.00 target price (up previously from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Cantor Fitzgerald restated an “overweight” rating and issued a $205.00 target price (up previously from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $187.00 target price (up previously from $186.00) on shares of UnitedHealth Group in a research note on Friday, April 21st. Finally, CIBC increased their price target on UnitedHealth Group from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, April 24th. One equities research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $203.41.

UnitedHealth Group (NYSE UNH) traded down 0.8205% during trading on Friday, reaching $191.1189. The company had a trading volume of 1,258,048 shares. UnitedHealth Group has a one year low of $132.39 and a one year high of $196.04. The company has a market capitalization of $184.79 billion, a PE ratio of 22.9600 and a beta of 0.64. The firm’s 50 day moving average is $190.34 and its 200 day moving average is $175.66.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the prior year, the firm posted $1.96 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group will post $9.87 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Earns Buy Rating from Jefferies Group LLC” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/18/unitedhealth-group-incorporated-unh-earns-buy-rating-from-jefferies-group-llc.html.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,540 shares of company stock worth $2,873,320. Insiders own 0.89% of the company’s stock.

Several institutional investors have recently made changes to their positions in UNH. Patriot Financial Group Insurance Agency LLC boosted its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $110,000. Cribstone Capital Management LLC increased its position in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the last quarter. Kings Point Capital Management increased its position in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the last quarter. Finally, Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $114,000. 86.21% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.